Jiawei Jingxie Yin attenuates psoriasis recurrence and is associated with reduced NF-κB activation and memory γδ T cells in a mouse model
Pathology - Research and Practice · 2026-08 · 284 · 156483
DOI: 10.1016/j.prp.2026.156483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026-08. Verfasst von Yu Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Kunming Hospital of Traditional Chinese Medicine, Kunming 650500, China. Hauptthemen laut MEDLINE: Psoriasis, NF-kappa B, Drugs, Chinese Herbal, Immunologic Memory. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Psoriasis frequently relapses after treatment withdrawal, suggesting persistence of cutaneous immune memory. Jiawei Jingxie Yin (JWJXY) is clinically used for psoriasis, but its relapse-related immunologic effects remain insufficiently characterized. Imiquimod (IMQ)-induced psoriasis and an IMQ rechallenge recurrence model were established in BALB/c mice. JWJXY (8/16/32 g/kg) was administered orally for 7 consecutive days. Lesion severity was assessed using PASI scoring. Epidermal pathology was evaluated by H&E staining. Serum IL-1β, IL-6, IL-18 and CXCL1 were measured by enzyme-linked immunosorbent assay (ELISA) kit. Keratinocyte hyperproliferation markers (K6, K16, Ki67) and TCRγδ in skin were assessed by immunofluorescence. NF-κB pathway activation (NF-κB, p-NF-κB, IκBα, p-IκBα) was assessed by western blot. Memory γδ T cells (CD44 +TCRγδ+) were quantified by flow cytometry in the recurrence setting. JWJXY dose-dependently improved IMQ-induced lesions and reduced PASI scores, accompanied by reduced epidermal hyperplasia and decreased K6/K16/Ki67 expression. JWJXY lowered serum IL-1β, IL-6, IL-18 and CXCL1. NF-κB pathway activation markers were reduced, including decreased p-NF-κB and p-IκBα. In the recurrence model, JWJXY attenuated rechallenge-associated disease severity and reduced cutaneous TCRγδ signal and memory γδ T-cell frequency. JWJXY ameliorated IMQ-induced psoriasis and attenuated recurrence, with associated reductions in systemic inflammatory mediators, keratinocyte hyperproliferation markers, NF-κB activation markers, and γδ T-cell readouts. Because Th17 cells and cellular IL-17A sources were not directly quantified, IL-17-axis interpretations should be considered hypothesis-generating and require confirmation; formal toxicity testing (e.g., serum chemistry) is also needed in future work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Kunming Hospital of Traditional Chinese Medicine, Kunming 650500, China.
- Dermatology Department, Kunming Hospital of Traditional Chinese Medicine, Kunming 650500, China. Electronic address: 13987131771@163.com.
Zitieren
APA
Lu, Y., Zhou, X., Yang, D., & Wu, J. (2026). Jiawei Jingxie Yin attenuates psoriasis recurrence and is associated with reduced NF-κB activation and memory γδ T cells in a mouse model. Pathology - Research and Practice, 284, 156483. https://doi.org/10.1016/j.prp.2026.156483
Vancouver
Lu Y, Zhou X, Yang D, Wu J. Jiawei Jingxie Yin attenuates psoriasis recurrence and is associated with reduced NF-κB activation and memory γδ T cells in a mouse model. Pathology - Research and Practice. 2026;284:156483. doi:10.1016/j.prp.2026.156483
BibTeX
@article{Lu2026,
author = {Lu, Yu and Zhou, Xiaomei and Yang, Dengke and Wu, Jie},
title = {Jiawei Jingxie Yin attenuates psoriasis recurrence and is associated with reduced NF-κB activation and memory γδ T cells in a mouse model},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {284},
pages = {156483},
doi = {10.1016/j.prp.2026.156483}
}
EUVIMED